Prevention of radiotherapy-induced emesis

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 1, 2003, Pages 17-22

  Tonini, G ^a   Vincenzi, Bruno ^a   Santini, D ^a   La Cesa, A ^a   Finolezzi, E ^a   Onori, N ^a   D'Angelillo, R ^a,b   Baldi, A ^c   Trodella, L ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

5 HT3; Cancer; Emesis; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; BENZAMIDE DERIVATIVE; CHLORPROMAZINE; DEXAMETHASONE; DIAZEPAM; DOLASETRON MESILATE; GRANISETRON; HALOPERIDOL; LORAZEPAM; METOCLOPRAMIDE; ONDANSETRON; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON;

ARTICLE; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MECHANISM; HUMAN; INCIDENCE; LATENT PERIOD; NAUSEA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED EMESIS; RISK FACTOR; WHOLE BODY RADIATION;

ANTIEMETICS; CLINICAL TRIALS; HUMANS; NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK FACTORS; VOMITING;

EID: 0037350829     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Italian Group for Antiemetic Research in Radioterapy: Radiation-induced emesis: a prospective observational multicenter Italian trial. Int. J. Radiat. Oncol. Biol. Phys. Jun: 1;44, 1999.
2. Fowler J., Lindstrom M.: Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23: 457-467, 1992.
3. Coates A., Abraham S.K., Kaye S.B.: On the receiving end: patient perception of the side effects of cancer chemotherapy. Eur. J. Cancer Clin. Oncol. 19: 203, 1983.
4. Feyer P.C., Stewart A.L., Titlbach O.J.: Aetiology and prevention of emesis induced by radiotherapy. Support Care Cancer 6: 253-260, 1998.
5. Scarantino C.W., Ornitz R.D., Hoffman L.G., Anderson R.F. Jr.: Radiation-induced emesis: effects of ondansetron. Semin. Oncol. 19(6 Suppl 15):38-43, 1992.
6. Jeremic B.: Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation. Srp. Arh. Celok. Lek. 124(5-6):131-134, 1996.
7. Harding R.K., Young R.W., Anno G.H.: Radiotherapy-induced emesis. In: Andrews P.L.R., Sanger G.J., eds. Emesis in anticancer therapy mechanisms and treatment. London: Chapman and Hall, 1993: 163-178.
8. Bremer K.: Individuelle risiko-adaptierte antiemetische Stufentherapie. Dtsch. Med. Wochenschr 119:598-604, 1994.
9. Spitzer T.R., Deeg H.J., Torrisi J.: Total body irradiation-induced emesis in universal after small dose fractions(120 cGy) and is not cumulative dose related. Proc. Am. Soc. Clin. Oncol. 9:14, 1990.
10. Buchali A., Feyer P., Groll J., Massenkeil G., Arnold R., Budach V.: Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother. Oncol. Feb;54(2):157-162, 2000.
11. Danjoux E., Rider W.D., Fritzpatrick P.J.: The acute radiation syndrome. Clin. Radiol. 30:581-584, 1979.
12. Feyer P., Zimmermann J.S., Titlbach O.J., Buchali A., Hinkelbein M., Budach V.: Radiotherapy-induced emesis. An overview. Strahlenther Onkol. Nov;174 Suppl 3:56-61, 1998.
13. Priestman T.J.: Clinical studies with ondansetron in the control of radiation-induced emesis. Eur. J. Cancer Clin. Oncol. 251: 29-33, 1989.
14. Schwella N., Konig V., Schwerdtfeger R., et al.: Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant 13: 169-171, 1994.
15. Feyer P.: Ondansetron in radiotherapy-induced emesis. J. Pharmacol. Ther. 4:112-113, 1995.
16. Hunter A.E., Prentice H.G., Pothecary K.,et al.: Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone Marrow Transplant 7(6):439-441, 1991.
17. Henriksson R., Lomberg H., Israelsson G., Zackrisson B., Franzen L.: The effect of ondansetron on radiation-induced emesis and diarrhoea. Acta Oncol. 31(7):767-769, 1992.
18. Roberts J.T., Priestman T.: A review of ondansetron in the management of radiotherapy-induced emesis. Oncology 50(3):173-179, 1993.
19. Maisano R., Pergolizzi S., Settineri N.: Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Anticancer Res. 18:2011-2013, 1998.
20. Roberts J.T., Priestman T.J.: A review of ondansetron in the management of radiotherapy-induced emesis. Oncology 50(3):173-179, 1993.
21. Priestman T.J., Roberts J.T., Lucraft H., et al.: Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin. Oncol. (R. Coll. Radiol.) 2(2):71-75, 1990.
22. Spitzer T.R., Bryson J.C., Cirenza E., et al.: Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J. Clin. Oncol. 12(11):2432-2438, 1994.
23. Bey P., Wilkinson P.M., Resbeut M., et al.: A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer 4(5):378-383, 1996.
24. Prentice H.G., Cunningham S., Gandhi L., Cunningham J., Collis C., Hamon M.: Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15(3):445-448, 1995.
25. Sykes A.J., Kiltie A.E., Stewart A.: Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5(6):500-503, 1997.
26. Aass N., Hatun D.E., Thoresen M., Fossa S.: Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. Radiother. Oncol. 45(2):125-128, 1997.
27. Gralla R.J., Osoba D., Kris M.G., et al.: Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J. Clin. Oncol. Sep; 17(9):2971-2994, 1999.
28. Franzen L., Nyman J., Hagberg H., et al.: A randomised placebo controlled study with ondansetron in patient undergoing fractionated radiotherapy. Ann. Oncol. 7: 587-592, 1996.
29. Priestman S.G., Priestman T.J., Canney P.A.: A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea. Clin. Radiol. 38: 543-544, 1987.
30. Kirkbride P., Pater J., Zee B., et al.: A phase III study of the efficacy of dexamethasone (DEX) in the prophylaxis of radiation induced emesis (RIE). Proc. Am. Soc. Clin. Oncol. 17: 51, 1998.